Effector pathways in immune mediated central nervous system demyelination

被引:46
作者
Kieseier, BC
Storch, MK
Archelos, JJ
Martino, G
Hartung, HP
机构
[1] Karl Franzens Univ Graz, Dept Neurol, A-8036 Graz, Austria
[2] Ist Sci San Raffaele, DIBIT, Dept Neurol, Expt Neuroimmunotherapy Unit, I-20132 Milan, Italy
关键词
D O I
10.1097/00019052-199906000-00011
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis is generally regarded to be a primarily T-cell driven disease. Recent evidence has refocused interest on antibodies. Adhesion molecules, matrix metalloproteinases, chemokines and cytokines, and nitric oxide and oxygen metabolites all participate in the amplification and effector stages of the disease. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:323 / 336
页数:14
相关论文
共 129 条
[91]   MULTIPLE-SCLEROSIS - IMMUNE-SYSTEM MOLECULE EXPRESSION IN THE CENTRAL-NERVOUS-SYSTEM [J].
RAINE, CS .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (04) :328-337
[92]   Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases [J].
Rawes, JA ;
Calabrese, VP ;
Khan, OA ;
DeVries, GH .
MULTIPLE SCLEROSIS, 1997, 3 (06) :363-369
[93]   Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible [J].
Redford, EJ ;
Kapoor, R ;
Smith, KJ .
BRAIN, 1997, 120 :2149-2157
[94]  
REINDL M, 1999, IN PRESS BRAIN
[95]   Effect of steroids on CSF matrix metalloproteinases in, multiple sclerosis: Relation to blood-brain barrier injury [J].
Rosenberg, GA ;
Dencoff, JE ;
Correa, N ;
Reiners, M ;
Ford, CC .
NEUROLOGY, 1996, 46 (06) :1626-1632
[96]  
ROSENBERG GA, 1994, LAB INVEST, V71, P417
[97]   TIMP-2 REDUCES PROTEOLYTIC OPENING OF BLOOD-BRAIN-BARRIER BY TYPE-IV COLLAGENASE [J].
ROSENBERG, GA ;
KORNFELD, M ;
ESTRADA, E ;
KELLEY, RO ;
LIOTTA, LA ;
STETLERSTEVENSON, WG .
BRAIN RESEARCH, 1992, 576 (02) :203-207
[98]  
Samoilova EB, 1998, J IMMUNOL, V161, P6480
[99]   Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery [J].
Samoilova, EB ;
Horton, JL ;
Chen, YH .
CELLULAR IMMUNOLOGY, 1998, 188 (02) :118-124
[100]  
SHRAGER P, 1998, J NEUROPHYSIOL, V56, P542